Uncategorized
VIBRANT study: Anti-VEGF outperforms laser treatment for BRVO
PHILADELPHIA — Aflibercept improved vision and reduced retinal thickness in eyes with branch retinal vein occlusion, according to a study presented here. Julia A. Haller, MD, gave results from the VIBRANT study at Macula 2014. “We see in the trial superiority of intravitreal aflibercept over laser treatment seen through week 24 in terms of visual acuity and anatomic outcomes,” Haller said. “The drug was well tolerated.”